NUTRIEN LTD (NTR.CA) Forecast, Price Target & Analyst Ratings
TSX:NTR • CA67077M1086
107.7 CAD
+4.3 (+4.16%)
Last: Mar 11, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NUTRIEN LTD (NTR.CA).
Forecast Snapshot
Consensus Price Target
CA$74.17
-31.13% Downside
Next Earnings Forecast
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate$0.49
Revenue Estimate5.263B
ChartMill Buy Consensus
72.59%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$74.17
Upside
-31.13%
From current price of CA$107.70 to mean target of CA$74.17, Based on 27 analyst forecasts
Low
CA$61.61
Median
CA$74.00
High
CA$89.25
Price Target Revisions
1 Month
6.49%
3 Months
10.44%
Price Target Summary
27 Wall Street analysts provided a forecast for the next 12 months for NTR.CA. The average price target is 74.17 CAD. This implies a price decrease of -31.13% is expected in the next year compared to the current price of 107.7.
The average price target has been revised upward by 10.44% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
72.59%
NTR.CA was analyzed by 27 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about NTR.CA.
In the previous month the buy percentage consensus was at a similar level.
NTR.CA was analyzed by 27 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-27 | OPPENHEIMER & CO., INC. | Maintains | Outperform -> Outperform |
| 2025-12-12 | Veritas Investment Research | Maintains | Buy -> Buy |
| 2022-11-17 | TD Research | Maintains | Buy |
| 2022-11-17 | Barclays | Downgrade | |
| 2022-11-07 | RBC Royalbank | Downgrade | Outperform |
| 2022-11-04 | Morningstar Inc. | Upgrade | Hold |
| 2022-11-04 | Raymond James Capital | Upgrade | Outperform |
| 2022-11-04 | TD Research | Downgrade | Buy |
| 2022-11-04 | Scotiabank Capital | Downgrade | Sector Perform |
| 2022-11-03 | Zacks Research Inc. | Maintains | Hold |
| 2022-11-03 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-11-01 | Mizuho Securities | Initiate | Hold |
| 2022-11-01 | STA Research | Maintains | Underperform |
| 2022-10-31 | TD Research | Downgrade | Hold |
| 2022-08-26 | Morningstar Inc. | Downgrade | Sell |
| 2022-08-26 | STA Research | Downgrade | Underperform |
| 2022-08-09 | Scotiabank Capital | Downgrade | Outperform |
| 2022-08-05 | BMO Financial | Downgrade | Outperform |
| 2022-08-05 | Morningstar | Upgrade | Hold |
| 2022-08-04 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-08-04 | STA Research | Maintains | Underperform |
| 2022-07-29 | TD Research | Downgrade | Buy |
| 2022-07-21 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-07-21 | STA Research | Downgrade | Underperform |
| 2022-07-14 | Scotiabank Capital | Maintains | Sector Perform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate$0.49
Revenue Estimate5.263B
Revenue Q2Q7.98%
EPS Q2Q347.79%
Number of Analysts17
Next Earnings Revisions
Revenue (1 Month)
0.32%
Revenue (3 Months)
0.32%
EPS (1 Month)
-15.41%
EPS (3 Months)
-24.51%
Next Earnings Summary
NTR.CA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.49 CAD and the consensus revenue estimate is 5.26B CAD.
The next earnings revenue estimate has been revised upward by 0.32% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 29.056B -23.30% | 25.972B -10.61% | 26.885B 3.52% | 26.401B -1.80% | 26.496B 0.36% | 26.635B 0.52% | 28.149B 5.68% | 28.634B 1.72% | 29.715B 3.78% | 30.356B 2.16% | 31.01B 2.15% | |
| EBITDA YoY % growth | 5.971B -49.65% | 5.288B -11.44% | 5.954B 12.59% | 6.136B 3.06% | 6.065B -1.16% | 6.121B 0.92% | 6.061B -0.98% | 6.254B 3.18% | 6.448B 3.10% | 6.55B 1.58% | 6.652B 1.56% | |
| EBIT YoY % growth | 3.802B -61.39% | 2.949B -22.44% | 3.585B 21.57% | 3.768B 5.10% | 3.687B -2.15% | 3.577B -2.98% | 3.51B -1.87% | 3.978B 13.33% | 3.866B -2.82% | 3.93B 1.66% | 3.995B 1.65% | |
| Operating Margin | 13.09% | 11.35% | 13.33% | 14.27% | 13.92% | 13.43% | 12.47% | 13.89% | 13.01% | 12.95% | 12.88% | |
| EPS YoY % growth | 4.36 -66.67% | 3.50 -19.72% | 4.56 30.29% | 4.81 5.57% | 4.76 -1.13% | 4.89 2.73% | 5.07 3.62% | 4.95 -2.23% | 4.96 0.10% | 5.05 1.83% | 5.15 2.00% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.49 347.79% | 2.69 1.38% | 0.77 -20.26% | 0.84 1.63% |
| Revenue Q2Q % growth | 5.263B 7.98% | 10.249B 0.50% | 5.748B 0.23% | 5.456B 6.11% |
| EBITDA Q2Q % growth | 1.082B 31.95% | 2.465B -18.51% | 1.318B -49.19% | 1.326B -56.85% |
| EBIT Q2Q % growth | 481.77M 93.48% | 1.885B 2.45% | 501.18M -36.72% | 769.62M 9.32% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
2.35%
EPS Next 5 Year
1.67%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
0.08%
Revenue Next 5 Year
1.51%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
17.92%
EBIT Next 5 Year
10.87%
NUTRIEN LTD / NTR.CA Forecast FAQ
What is the average price target for NUTRIEN LTD (NTR.CA) stock?
27 analysts have analysed NTR.CA and the average price target is 74.17 CAD. This implies a price decrease of -31.13% is expected in the next year compared to the current price of 107.7.
Can you provide the upcoming earnings date for NUTRIEN LTD?
NUTRIEN LTD (NTR.CA) will report earnings on 2026-05-06.
What are the consensus estimates for NUTRIEN LTD (NTR.CA) next earnings?
The consensus EPS estimate for the next earnings of NUTRIEN LTD (NTR.CA) is 0.49 CAD and the consensus revenue estimate is 5.26B CAD.
How many analysts cover NUTRIEN LTD (NTR.CA) stock?
The number of analysts covering NUTRIEN LTD (NTR.CA) is 27.